- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC Creates MACRA Compendium for Payers, Providers During Transition to Value-Based Care
With the Medicare Access and CHIP Reauthorization Act (MACRA) set to take effect January 1, 2017, The American Journal of Managed Care has created a resource center, the MACRA Compendium, where payers and providers can find updates on the transition to value-based care.
FOR IMMEDIATE RELEASEDecember 22, 2016
PLAINSBORO, N.J.—If you still don’t understand the Medicare Access and CHIP Reauthorization Act (MACRA), you’re not alone. While small practices have the greatest learning curve, even larger health systems may benefit from a convenient source of information on the 2015 law, which takes effect January 1, 2017.
With that in mind, The American Journal of Managed Care (AJMC) has created the MACRA Compendium, a resource center on www.ajmc.com that brings together news, commentary, and multimedia content on the law, which pushes Medicare’s transition from fee-for-service to value-based payment. You can find the center at http://www.ajmc.com/compendium/macra.
The MACRA Compendium features content from:
· The fall meeting of AJMC’s ACO & Emerging Healthcare Delivery Coalition, which discussed how accountable care organizations have laid the groundwork for MACRA.
· Commentary from several AJMC contributors, including Greg Fulton of Philips Wellcentive and heath information technology strategist Mark Heaney.
· Video interviews with CMS’ Kate Goodrich, MD, on how physicians can successfully adapt to the Merit-Based Incentive Payment System.
To contribute commentary to the MACRA Compendium, contact Editorial Director Nicole Beagin at (609) 716-7777 x 131.
About the Journals and AJMC.com
The American Journal of Managed Care is the leading peer-reviewed journal dedicated to issues in managed care. AJMC.com distributes healthcare news to leading stakeholders across a variety of platforms. Other titles in the franchise include The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
,
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
New TROPiCS-02 Data Back Sacituzumab Govitecan for Older Patients With Breast Cancer
December 9th 2023This phase 3 study investigated sacituzumab govitecan, a Trop-2–directed antibody-drug conjugate, vs treatment of physician’s choice in pretreated patients who have endocrine-resistant hormone receptor–positive/HER2-negative breast cancer, the most common form of breast cancer.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
What We’re Reading: RSV Vaccine Demand; Permanent Contraception; Drug Negotiation Impact
December 8th 2023The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them to increase access to the vaccine; since the Dobbs v Jackson decision, many patients have been seeking more permanent reproductive health care solutions; a Mathematica analysis showed that Medicare prescription drug price negotiations could have cut seniors’ out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
Read More
